Investigating new treatments for infectious diseases through clinical trials
Early Phase Clinical Trial Units (EPCTU)
This study is looking for people to try out new treatments for infectious diseases that aren't available yet, so if you join, you'll get to help test these therapies while being closely watched for safety and effectiveness.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11259400 on NIH RePORTER |
What this research studies
The Early Phase Clinical Trial Units focus on testing new agents aimed at treating and preventing infectious diseases. This research involves implementing interventional clinical trials, which means that patients may receive new therapies that are not yet widely available. Participants will be closely monitored throughout the trial to assess the effectiveness and safety of these new treatments. The goal is to gather valuable data that can lead to improved options for managing infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with infectious diseases who are seeking new treatment options.
Not a fit: Patients with non-infectious diseases or those who do not meet the specific criteria for the trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for infectious diseases, improving patient outcomes.
How similar studies have performed: Previous research has shown success in similar early phase clinical trials, indicating a promising approach to developing new treatments.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Naggie, Susanna — Duke University
- Study coordinator: Naggie, Susanna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.